Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts

Photodermatology Photoimmunology and Photomedicine

Volumn 27, Issue 2, 2011, Pages 90-96

  Cai, Hong ^a   Gu, Ying ^b   Sun, Qiang ^b   Zeng, Jing ^b   Dong, Ning ^b   Zhao, Guang ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Caspase 3; Fibroblast; Photodynamic therapy; Photosensitizer

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE 3; HEMATOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN MONOMETHYL ETHER; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; FIBROBLAST CULTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOFLUORESCENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

APOPTOSIS; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPORPHYRINS; HUMANS; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY;

EID: 79952517037     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00577.x     Document Type: Article

References (38)

1. Lee JY, Yang CC, Chao SC, Wong TW. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 2004; 26: 379-384.
2. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 2006; 8: 362-368.
3. Zurada JM, Kriegel D, Davis IC. Topical treatments for hypertrophic scars. J Am Acad Dermatol 2006; 55: 1024-1031.
4. Blazic TM, Brajac I. Defective induction of senescence during wound healing is a possible mechanism of keloid formation. Med Hypotheses 2006; 66: 649-652.
5. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001; 107: 87-96.
6. Messadi DV, Le A, Berg S, et al. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999; 7: 511-517.
7. Wlaschek M, Ma W, Jansen DP, Scharffetter KK. Photoaging as a consequence of natural and therapeutic ultraviolet irradiation-studies on PUVA-induced senescence-like growth arrest of human dermal fibroblasts. Exp Gerontol 2003; 38: 1265-1270.
8. Moor AC. Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 2000; 57: 1-13.
9. Jarvi MT, Niedre MJ, Patterson MS, Wilson BC. Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects. Photochem Photobiol 2006; 82: 1198-1210.
10. Morton CA. Realizing the cosmetic potential of topical photodynamic therapy. J Cosmet Dermatol 2002; 1: 66-71.
11. Nootheti PK, Goldman MP. Aminolevulinic acid-photodynamic therapy for photorejuvenation. Dermatol Clin 2007; 25: 35-45.
12. Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006; 16: 340-348.
13. Karrer S, BosserhoV AK, Weidere P, Landthaler M, Szeimirs RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of metalloproteinases in Wbroblasts. Br J Dermatol 2004; 151: 776-783.
14. Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 2005; 21: 157-165.
15. Takahashi H, Komatsu S, Ibe M, et al. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT. Arch Dermatol Res 2006; 298: 257-263.
16. Chiu LL, Sun CH, Yeh AT, et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Laser Surg Med 2005; 37: 231-244.
17. Strong LH, Berthiaume F, Yarmush ML. Control of fibroblast populated collagen lattice contraction by antibody targeted photolysis of fibroblasts. Laser Surg Med 1997; 21: 235-247.
18. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 2003; 120: 325-331.
19. Adili F, Statius RG, Flotte TJ, LaMuraglia GM. Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia. Lasers Surg Med 1998; 23: 263-273.
20. LaMuraglia GM, Schiereck J, Heckenkamp J, et al. Photodynamic therapy induces apoptosis in intimal hyperplastic arteries. Am J Pathol 2000; 157: 867-875.
21. Chowdhury I, Tharakan B, Bhat GK. Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 2006; 11: 506-525.
22. Furre IE, Moller MT, Shahzidi S, Nesland JM, Peng Q. Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis 2006; 11: 2031-2042.
23. Ericson M, Sandberg C, Stenquist B, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204-1212.
24. Lang K, Schulte KW, Ruzicka T, Fritsch C. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses. Skin Therapy Lett 2001; 6: 1-2.
25. Ying G, Liu FG, Wang K, Zhu JG, Liang J, Pan YM. A clinic analysis of 1216 cases of port wine stain treated by photodynaimic therapy, Chin. J Laser Med Surg 2001; 10: 86-89 (in Chinese).
26. De FB, Ciarmiello LF, Mondola P, et al. Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts. DNA Cell Biol 2007; 26: 541-547.
27. Tanaka A, Hatoko M, Tada H, Iioka H, Niitsuma K, Miyagawa S. Expression of p53 family in scars. J Dermatol Sci 2004; 34: 17-24.
28. Schouwink H, Ruevekamp M, Oppelaar H, Van VR, Baas P, Stewart FA. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols. Photochem Photobiol 2001; 73: 410-417.
29. Xue L, He J, Oleinick NL. Promotion of photodynamic therapy-induced apoptosis by stress kinases. Cell Death Differ 1999; 6: 855-864.
30. Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer 1994; 70: 21-28.
31. Phan TT, Lim IJ, Bay BH, et al. Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J Dermatol Sci 2002; 29: 26-34.
32. Ding X, Xu Q, Liu F, et al. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett 2004; 216: 43-54.
33. Kaiser HE, Bodey B. The role of apoptosis in normal ontogenesis and solid human neoplasms. In vivo 2000; 14: 789-803.
34. Piette J, Volanti C, Vantieghem A, Matroule JY, Habraken Y, Agostinis P. Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem Pharmacol 2003; 66: 1651-1659.
35. Akasaka Y, Ishikawa Y, Ono I, et al. Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest 2000; 80: 345-357.
36. Wang F, Chen TS, Xing D, Wang JJ, Wu YX. Measuring dynamics of caspase-3 activity in living cells using FRET technique during apoptosis induced by high fluence low-power laser irradiation. Laser Surg Med 2005; 36: 2-7.
37. Yang XH, Edgerton S, Thor AD. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int J Oncol 2005; 26: 1675-1680.
38. Draper DW, Harris VG, Culver CA, Laster SM. Calcium and its role in the nuclear translocation and activation of cytosolic phospholipase A2 in cells rendered sensitive to TNF-induced apoptosis by cycloheximide. J Immunol 2004; 172: 2416-2423.